Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Jones

Showing results (401-410 of 459) with videos related to

Pageof 46
Sort By:
Biochemistry|November 29, 2001
Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifsS Ye, Y Luo, W Lu, et al.
Progress in Clinical and Biological Research|January 1, 1990
The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantationW P Peters, J Kurtzberg, S Atwater, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic studyW P Peters, A Stuart, M Klotman, et al.
Cancer|August 1, 1990
The Duke AFM Program. Intensive induction chemotherapy for metastatic breast cancerR B Jones, E J Shpall, J Shogan, et al.
Alimentary Pharmacology & Therapeutics|August 6, 1998
Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradicationK D Bardhan, D Morton, D N Slater, et al.
Hematology/Oncology Clinics of North America|April 1, 1996
Bone marrow metastasesE J Shpall, A P Gee, C Hogan, et al.
Current Opinion in Hematology|November 1, 1995
Stem cell isolationE J Shpall, A Gee, P J Cagnoni, et al.
Cancer Treatment Reports|September 1, 1981
Phase I trial of pentamethylmelamine: a clinical and pharmacologic studyD C Ihde, J S Dutcher, R C Young, et al.
Archives of Disease in Childhood|May 1, 1983
Partial galactose disorders in families with premature cataractsA F Winder, L J Claringbold, R B Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancerP J Cagnoni, Y Nieto, E J Shpall, et al.
Pageof 46

Showing results (401-410 of 459) with videos related to

Sort By:
Pageof 46
Biochemistry|November 29, 2001
Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifsS Ye, Y Luo, W Lu, et al.
Progress in Clinical and Biological Research|January 1, 1990
The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantationW P Peters, J Kurtzberg, S Atwater, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic studyW P Peters, A Stuart, M Klotman, et al.
Cancer|August 1, 1990
The Duke AFM Program. Intensive induction chemotherapy for metastatic breast cancerR B Jones, E J Shpall, J Shogan, et al.
Alimentary Pharmacology & Therapeutics|August 6, 1998
Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradicationK D Bardhan, D Morton, D N Slater, et al.
Hematology/Oncology Clinics of North America|April 1, 1996
Bone marrow metastasesE J Shpall, A P Gee, C Hogan, et al.
Current Opinion in Hematology|November 1, 1995
Stem cell isolationE J Shpall, A Gee, P J Cagnoni, et al.
Cancer Treatment Reports|September 1, 1981
Phase I trial of pentamethylmelamine: a clinical and pharmacologic studyD C Ihde, J S Dutcher, R C Young, et al.
Archives of Disease in Childhood|May 1, 1983
Partial galactose disorders in families with premature cataractsA F Winder, L J Claringbold, R B Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancerP J Cagnoni, Y Nieto, E J Shpall, et al.
Pageof 46